Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01605500 · ClinicalTrials.gov registry record
Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators
A clinical trial, sponsored by Englewood Hospital and Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT01605500 is a clinical trial that has completed, run by Englewood Hospital and Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT01605500 has completed, sponsored by Englewood Hospital and Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the alert tones emitted by the latest generation of Medtronic implantable cardioverter-defibrillators (ICDs) are audible to patients. ICD patients can have difficulties hearing the beeps, which are designed to notify patients of possible lead or generator malfunction. In fact, the only published study of this issue, conducted at Englewood Hospital and Medical Center, revealed that only 50% of patients with older Medtronic devices were able to hear alerts. Since then, modifications to the alert have been made by Medtronic. This study will establish the "real-world" value of these changes and also provide useful in vivo information regarding the validity of the in vitro techniques which have been used thus far to design the Patient Alert feature.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01605500
The ClinicalTrials.gov registry entry for NCT01605500 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Englewood Hospital and Medical Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01605500 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01605500 about?
NCT01605500 is a clinical study titled "Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators". The purpose of this study is to determine whether the alert tones emitted by the latest generation of Medtronic implantable cardioverter-defibrillators (ICDs) are audible to patients. ICD patients can have difficulties hearing the beeps, which are designed to notify patients of possible lead or gen...
What is the current status of trial NCT01605500?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2012-06. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT01605500?
This trial is sponsored by Englewood Hospital and Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.